Found 242 results
Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is S  [Clear All Filters]
2020
E. J. Anderson, Rouphael, N. G., Widge, A. T., Jackson, L. A., Roberts, P. C., Makhene, M., Chappell, J. D., Denison, M. R., Stevens, L. J., Pruijssers, A. J., McDermott, A. B., Flach, B., Lin, B. C., Doria-Rose, N. A., O'Dell, S., Schmidt, S. D., Corbett, K. S., Swanson, P. A., Padilla, M., Neuzil, K. M., Bennett, H., Leav, B., Makowski, M., Albert, J., Cross, K., Edara, V. Viswanadh, Floyd, K., Suthar, M. S., Martinez, D. R., Baric, R., Buchanan, W., Luke, C. J., Phadke, V. K., Rostad, C. A., Ledgerwood, J. E., Graham, B. S., and Beigel, J. H., Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults., N Engl J Med, 2020.
F. M. Munoz, Patel, S. M., Jackson, L. A., Swamy, G. K., Edwards, K. M., Frey, S. E., Petrie, C. R., Sendra, E. A., and Keitel, W. A., Safety and immunogenicity of three seasonal inactivated influenza vaccines among pregnant women and antibody persistence in their infants., Vaccine, vol. 38, no. 33, pp. 5355-5363, 2020.
A. Hendrick, VanVeldhuisen, P. C., Scott, I. U., King, J., Blodi, B. A., Ip, M. S., Khurana, R. N., and Oden, N. L., SCORE2 Report 13: Intraretinal Hemorrhage Changes in Eyes With Central or Hemiretinal Vein Occlusion Managed With Aflibercept, Bevacizumab or Observation. Secondary Analysis of the SCORE and SCORE2 Clinical Trials., Am J Ophthalmol, vol. 222, pp. 185-193, 2020.
J. B. Patel, Wilson, S. H., Oakes, T. R., Santhanam, P., and Weaver, L. K., Structural and Volumetric Brain MRI Findings in Mild Traumatic Brain Injury., AJNR Am J Neuroradiol, vol. 41, no. 1, pp. 92-99, 2020.
2019
J. M. Marrazzo, Dombrowski, J. C., Wierzbicki, M. R., Perlowski, C., Pontius, A., Dithmer, D., and Schwebke, J., Safety and Efficacy of a Novel Vaginal Anti-infective, TOL-463, in the Treatment of Bacterial Vaginosis and Vulvovaginal Candidiasis: A Randomized, Single-blind, Phase 2, Controlled Trial., Clin Infect Dis, vol. 68, no. 5, pp. 803-809, 2019.
T. A. Crowell, Colby, D. J., Pinyakorn, S., Sacdalan, C., Pagliuzza, A., Intasan, J., Benjapornpong, K., Tangnaree, K., Chomchey, N., Kroon, E., de Souza, M. S., Tovanabutra, S., Rolland, M., Eller, M. A., Paquin-Proulx, D., Bolton, D. L., Tokarev, A., Thomas, R., Takata, H., Trautmann, L., Krebs, S. J., Modjarrad, K., McDermott, A. B., Bailer, R. T., Doria-Rose, N., Patel, B., Gorelick, R. J., Fullmer, B. A., Schuetz, A., Grandin, P. V., O'Connell, R. J., Ledgerwood, J. E., Graham, B. S., Tressler, R., Mascola, J. R., Chomont, N., Michael, N. L., Robb, M. L., Phanuphak, N., and Ananworanich, J., Safety and efficacy of VRC01 broadly neutralising antibodies in adults with acutely treated HIV (RV397): a phase 2, randomised, double-blind, placebo-controlled trial., Lancet HIV, vol. 6, no. 5, pp. e297-e306, 2019.
H. M. El Sahly, Atmar, R. L., Patel, S. M., Bellamy, A., Liu, L., Hong, W., Zhu, H., Guan, Y., and Keitel, W. A., Safety and immunogenicity of an 8 year interval heterologous prime-boost influenza A/H7N7-H7N9 vaccination., Vaccine, vol. 37, no. 19, pp. 2561-2568, 2019.
K. Modjarrad, Roberts, C. C., Mills, K. T., Castellano, A. R., Paolino, K., Muthumani, K., Reuschel, E. L., Robb, M. L., Racine, T., Oh, M. - D., Lamarre, C., Zaidi, F. I., Boyer, J., Kudchodkar, S. B., Jeong, M., Darden, J. M., Park, Y. K., Scott, P. T., Remigio, C., Parikh, A. P., Wise, M. C., Patel, A., Duperret, E. K., Kim, K. Y., Choi, H., White, S., Bagarazzi, M., May, J. M., Kane, D., Lee, H., Kobinger, G., Michael, N. L., Weiner, D. B., Thomas, S. J., and Maslow, J. N., Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial., Lancet Infect Dis, vol. 19, no. 9, pp. 1013-1022, 2019.
C. Carter, Houser, K. V., Yamshchikov, G. V., Bellamy, A. R., May, J., Enama, M. E., Sarwar, U., Larkin, B., Bailer, R. T., Koup, R., Chen, G. L., Patel, S. M., Winokur, P., Belshe, R., Dekker, C. L., Graham, B. S., and Ledgerwood, J. E., Safety and immunogenicity of investigational seasonal influenza hemagglutinin DNA vaccine followed by trivalent inactivated vaccine administered intradermally or intramuscularly in healthy adults: An open-label randomized phase 1 clinical trial., PLoS One, vol. 14, no. 9, p. e0222178, 2019.
F. M. Munoz, Anderson, E. J., Bernstein, D. I., Harrison, C. J., Pahud, B., Anderson, E., C Creech, B., Berry, A. A., Kotloff, K. L., Walter, E. B., Atmar, R. L., Bellamy, A. R., Chang, S., and Keitel, W. A., Safety and immunogenicity of unadjuvanted subvirion monovalent inactivated influenza H3N2 variant (H3N2v) vaccine in children and adolescents., Vaccine, vol. 37, no. 36, pp. 5161-5170, 2019.
T. L. Schonfeld, Brown, J. S., N Amoura, J., and Gordon, B. G., Strength through Structure: Defending a Structured Approach to Contraceptive Mandates in Clinical Research., Ethics Hum Res, vol. 41, no. 3, pp. 33-35, 2019.
D. Collie, Gay, K., Sheikh, M., Esterlitz, J., Saver, J., Warach, S., and Janis, Son behalf, Stroke Version 2.0 Common Data Element (CDE) Review: Updates to the National Institute of Neurological Disorders and Stroke (NINDS) CDEs for Stroke, in American Academy of Neurology 71st Annual Meeting, Philadelphia, PA, 2019.
M. S. Natrajan, Rouphael, N., Lai, L., Kazmin, D., Jensen, T. L., Weiss, D. S., Ibegbu, C., Sztein, M. B., Hooper, W. F., Hill, H., Anderson, E. J., Johnson, R., Sanz, P., Pulendran, B., Goll, J. B., and Mulligan, M. J., Systems Vaccinology for a Live Attenuated Tularemia Vaccine Reveals Unique Transcriptional Signatures That Predict Humoral and Cellular Immune Responses., Vaccines (Basel), vol. 8, no. 1, 2019.
2018
F. M. Munoz, Jackson, L. A., Swamy, G. K., Edwards, K. M., Frey, S. E., Stephens, I., Ault, K., Winokur, P., Petrie, C. R., Wolff, M., Patel, S. M., and Keitel, W. A., Safety and immunogenicity of seasonal trivalent inactivated influenza vaccines in pregnant women., Vaccine, vol. 36, no. 52, pp. 8054-8061, 2018.
R. A. Annunziato, Bucuvalas, J. C., Yin, W., Arnand, R., Alonso, E. M., Mazariegos, G. V., Venick, R. S., Stuber, M. L., Shneider, B. L., and Shemesh, E., Self-Management Measurement and Prediction of Clinical Outcomes in Pediatric Transplant., J Pediatr, vol. 193, pp. 128-133.e2, 2018.
H. S. L. Jim, Sutton, S., Majhail, N. S., Wood, W. A., Jacobsen, P. B., Wingard, J. R., Wu, J., Knight, J. M., Syrjala, K. L., and Lee, S. J., Severity, course, and predictors of sleep disruption following hematopoietic cell transplantation: a secondary data analysis from the BMT CTN 0902 trial., Bone Marrow Transplant, vol. 53, no. 8, pp. 1038-1043, 2018.
M. Samai, Seward, J. F., Goldstein, S. T., Mahon, B. E., Lisk, D. Radcliffe, Widdowson, M. - A., Jalloh, M. I., Schrag, S. J., Idriss, A., Carter, R. J., Dawson, P., Kargbo, S. A. S., Leigh, B., Bawoh, M., Legardy-Williams, J., Deen, G., Carr, W., Callis, A., Lindblad, R., Russell, J. B. W., Petrie, C. R., Fombah, A. E., Kargbo, B., McDonald, W., Jarrett, O. D., Walker, R. E., Gargiullo, P., Bash-Taqi, D., Gibson, L., Fofanah, A. Bakarr, and Schuchat, A., The Sierra Leone Trial to Introduce a Vaccine Against Ebola: An Evaluation of rVSV∆G-ZEBOV-GP Vaccine Tolerability and Safety During the West Africa Ebola Outbreak., J Infect Dis, vol. 217, no. suppl_1, pp. S6-S15, 2018.
D. Chiang, Chen, X., Jones, S. M., Wood, R. A., Sicherer, S. H., A Burks, W., Leung, D. Y. M., Agashe, C., Grishin, A., Dawson, P., Davidson, W. F., Newman, L., Sebra, R., Merad, M., Sampson, H. A., Losic, B., and M Berin, C., Single-cell profiling of peanut-responsive T cells in patients with peanut allergy reveals heterogeneous effector T2 subsets., J Allergy Clin Immunol, vol. 141, no. 6, pp. 2107-2120, 2018.
S. N. Taylor, Marrazzo, J., Batteiger, B. E., Hook, E. W., Seña, A. C., Long, J., Wierzbicki, M. R., Kwak, H., Johnson, S. M., Lawrence, K., and Mueller, J., Single-Dose Zoliflodacin (ETX0914) for Treatment of Urogenital Gonorrhea., N Engl J Med, vol. 379, no. 19, pp. 1835-1845, 2018.
J. M. Walker, Mulatya, C., Hebert, D., Wilson, S. H., Lindblad, A. S., and Weaver, L. K., Sleep assessment in a randomized trial of hyperbaric oxygen in U.S. service members with post concussive mild traumatic brain injury compared to normal controls., Sleep Med, vol. 51, pp. 66-79, 2018.